课题基金 / 基金详情

SYNCHROTRON CRYSTALLOGRAPHY OF ENZYMES AT BEAMLINE X 9B: HIV, DRUG TARGET

SYNCHROTRON CRYSTALLOGRAPHY OF ENZYMES AT BEAMLINE X 9B: HIV, DRUG TARGET
光束线 X 9B 上酶的同步晶体学:HIV、药物靶标
批准号:
6120424
负责人:
ZBIGNIEW DAUTER
金额:
$0.34万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 1999-08-31

项目摘要

项目成果

ZBIGNIEW DAUTER的其他基金

相似基金

相关文献

中文摘要
翻译
罗阿情结 晶体弱衍射至约4.5A 分辨率 采集140帧,每帧振荡0.5度。 曝光时间为30秒。 由于各向异性的 衍射图的数据仅在6A分辨率下才完整。 数据的整体完整性为86.2%。 数据的Rsym为 12%,整体冗余度为6。 总I/sigma为11.0(1.9 in 最后一个分辨率shell)。 这些数据目前用于分子 为了解决结构问题而进行的替换尝试。 PAF 乙酰水解酶突变体R22K。 数据采集至1.9A 分辨率 数据的整体完整性为90%。 与 冗余度为5.4时,在20~1.9A的分辨率范围内,Rsym为7%。 该结构处于晶体学细化的最后阶段。
英文摘要
Rhoa complex. The crystals diffracted weakly to about 4.5A resolution. 140 frames were collected with oscillation of 0.5deg per frame and 30 seconds of exposure time. Due to the anisomorphism of the diffraction pattern the data are complete only to 6A resolution. The overall completeness of the data is 86.2%. Rsym for the data is 12% with the overall redundancy of 6. Overall I/sigma is 11.0 (1.9 in the last resolution shell). The data is currently used in molecular replacement attempts in order to solve the structure. PAF Acetylhydrolase mutant R22K. The data were collected to 1.9A resolution. The overall completeness of the data is 90%. With the redundancy of 5.4 the Rsym is 7% in resolution range from 20A to 1.9A. The structure is in the final stages of crystallographic refinement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANALYSIS OF CRYSTAL STRUCTURES AT VERY HIGH RESOLUTION
  • 批准号:
    8361715
  • 项目类别:
  • 资助金额:
    $1.1万
  • 财政年份:
    2011
  • 负责人:
    ZBIGNIEW DAUTER
  • 依托单位:
XRAY DIFFRACTION OPERATIONS ON X9B
CRYSTAL STRUCTURE OF HUMAN RHOA GDP RHOGDI COMPLEX & ITS BIOLOGICAL IMPLICATIONS
ANOMALOUS SIGNAL OF SULFUR AS TOOL FOR SOLVING PROTEIN CRYSTAL STRUCTURES?
海外基金